News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hathaway Corporation Subsidiary Diabetes Detection, Inc. Signs Prominent Physicians for Its Scientific Advisory Board


12/4/2007 1:02:22 PM

PALO ALTO, CA--(Marketwire - December 04, 2007) - Hathaway Corporation (PINKSHEETS: HWYI) announced that its subsidiary, Diabetes Detection, Inc. (DDI), has been successful in signing two of the leading physicians and clinical researchers of Neuropathy and Diabetes treatments, for its Scientific Advisory Board. The highly respected physicians, who are authors of numerous research studies, papers and textbooks, have played significant leadership roles with various international Diabetes-related associations, including holding a past chairmanship of the American Diabetes Association. They have been responsible for, among other things, shaping the ADA's official position on Diabetic Neuropathies, and are strong and outspoken proponents for vibration testing for Neuropathy, the basis for DDI's technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES